Ultrix Quadri, 0.5 ml/dose 0.5 ml

Pharmacotherapeutic group.

MIBP vaccine.

The ATX code: J07BB02.

Inactivated purified split influenza vaccine. Prevents disease caused by influenza virus types A and B.

Induces the formation of humoral antibodies to hemagglutinins that neutralize influenza viruses. Seroprotective level of antibodies is usually achieved within 7-10 days after vaccine administration. The duration of postvaccinal immunity to homologous or related strains varies from 6 to 12 months.

Indications

Active annual prophylactic immunization against seasonal influenza in children aged 6 years and older, adolescents and adults up to 60 years of age.

The vaccine is especially indicated:

How to take, the dosage

Interaction

Special Instructions

The used and unused syringes and vials shall be disposed in accordance with the requirements of applicable law.

The drug does not affect the ability to drive vehicles or engage in other potentially dangerous activities requiring increased concentration and quick psychomotor reactions.

Contraindications

In case of non-serious acute respiratory infections and acute intestinal diseases, the vaccination is carried out after normalization of the body temperature of the vaccinated; with chronic diseases in the acute stage the vaccination is carried out after convalescence (remission).

Do not administer intravenously!
Before vaccination the immunized must be examined by a doctor (paramedic) with mandatory thermometry. If the body temperature is higher than 37 ° C the vaccination is not carried out.

The rooms where the vaccination is carried out must be equipped with antishock therapy. The vaccinated person must be under the supervision of a health care worker for 30 minutes after vaccination.

Side effects

Pregnancy use